Clinical Trial Update: On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the optical quality of On-Eye Lotrafilcon B contact lenses over 12 hours; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperopia
• Myopia

Drugs mentioned

• Lotrafilcon B contact lenses (On-Eye) (Lotrafilcon B)

Snippet

Sponsor: Indiana University | Conditions: Hyperopia, Myopia | Phase 4 | Status: COMPLETED | Results posted: 2020-02-24